We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Therapeutic Goods Act 1989
Approval under section 42DF for use of restricted representations by Molnlycke Health Care Pty Ltd
I, Michael Shum, as a delegate of the Secretary to the Department of Health and Aged Care, on receipt of an application from Molnlycke Health Care Pty Ltd, have approved under section 42DF of the Therapeutic Goods Act 1989, the restricted representations described in paragraph (A), for use in advertisements for the product identified in paragraph (B) in the advertisement in which the restricted representations are used (including on the label and packaging of the goods).
(A)
- For the management of eczema, psoriasis and other dry skin conditions
- For the management of dry skin conditions, eczema and psoriasis
together, (the Representations).
(B)
- Products marketed as ' Epaderm Ointment’ and ‘Epaderm Junior Ointment’ under the following entry in the Australian Register of Therapeutic Goods (ARTG):
- Skin moisturizing/barrier dressing (ARTG 462185).
Dated this 10th day of December 24
Signed electronically
Michael Shum
Delegate of the Secretary to the Department of Health and Aged Care
Advertising and Compliance Education and Policy Section
Regulatory Compliance Branch